Quarterly Result30 May 2026, 04:21 pm
Norris Medicines Approves Audited Financial Results for FY26
AI Summary
Norris Medicines Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The board also approved the appointment of M/s. Dhiren Y Parikh & Co. as Internal Auditors for FY 2026-2027. The meeting commenced at 03:00 p.m. and concluded at 03:30 p.m.
Key Highlights
- Audited Financial Results for the quarter and year ended March 31, 2026, approved.
- M/s. Dhiren Y Parikh & Co. appointed as Internal Auditors for FY 2026-2027.
- Declaration of unmodified opinion on the Audited Financial Results enclosed.
Price Impact
More from NORRIS